Problem Identification: To systematically evaluate the literature for functional quality-oflife (QOL) outcomes following treatment for localized prostate cancer.
Data Evaluation: Of the 2,191 articles screened for relevance and quality, 24 articles were reviewed. Extracted data were tabulated by treatment type and sorted by dysfunction using a data-driven approach.
Synthesis: All treatments caused sexual dysfunction and urinary side effects. Radiation therapy caused bowel dysfunction, which could be long-term or resolved within a few years. Sexual function could take years to return. Urinary incontinence resolved within two years of surgery but worsened following radiation therapy. Fatigue was worse during treatment with adjuvant androgen-deprivation therapy, and some men experienced post-treatment fatigue for several years.
Conclusions: This review identified that QOL outcomes reported by men following different treatments for localized prostate cancer are mostly recorded using standardized healthrelated QOL outcome measures. Such outcome measures collect data about body system functions but limit understanding of men's QOL following treatment for prostate cancer. Holistic outcome measures are needed to capture data about men's QOL for several years following the completion of treatment for localized prostate cancer.
Implications for Practice: Nurses need to work with men to facilitate information sharing, identify supportive care needs, and promote self-efficacy, and they should make referrals to specialist services, as appropriate. (NICE, 2014) . Men with intermediate-and highrisk localized prostate cancer may also be offered androgen-deprivation therapy as an adjuvant to radiation therapy to maximize treatment
